KP Rx

Established in 2023, KP Rx is a 100% founder-owned investment firm specialising in private and early-stage public healthcare investments in Australia and New Zealand. Founded by Hashan De Silva and backed by Karst Peak Capital, the firm targets high-potential biotech, medical devices, diagnostics, and health tech companies at a pivotal inflection point of value creation.

Our Focus

Creating a portfolio of Australia’s most promising healthcare companies. Our focus is on companies at or after Series A, specifically biotech companies at Phase 2 or medical device companies at or after regulatory clearance.

• Small-molecule Drugs
• Biological Products
• Cell & Gene Therapies
• Medical Devices
• Diagnostic Technologies
• AI for Healthcare
• Healthcare Software / SaaS
• Data and Analytics